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Abstract 
Invasion of tumor in the liver requires surgical interventions that may reduce the effects or may eliminate the tumor-affected cells. The renewal 
of the hepatic vein and inferior vena cava has enabled most specialized oncologists and medical specialists to use advanced diagnostic methods in 
the treatment of the liver tumors. Liver resection has prolonged the lives of many patients and the invention of live donor organ transplants has 
effectively enabled the use of liver resection in most cancer centers across the world. By reviewing data from 10 articles, 21 surgical analyses were 
investigated and analyzed for the risks involved in the applications of reconstructions of hepatic vein and inferior vena cava in the surgical liver 
resection. The postoperative complications and the indications of reconstructions were mentioned. The results indicated that with these surgical 
procedures, complications are still involved but may be successful for particular patients. 
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Introduction 
The existence of malignant tumor attacking the hepatic 
vein and the inferior vena cava has presented a challenging 
impact in the surgical treatment of cancer patients. Vari-
ous reports have indicated successful excision of the hepatic 
vein and inferior vena cava through man-made vessels (1). 
Successful excision of these tumors at advanced stages via 
reconstruction during hepatic surgery resection has been 
invariably reported. Reconstruction of hepatic vein and infe-
rior vena cava to treat liver cancer is not necessarily the only 
available effective surgical therapeutic method, therefore it 
must be selected in exceptional cases of cancer treatment (2). 
This article tends to investigate through a literature search, 
the cases regarding the successful operation of hepatic vein 
and inferior vena cava reconstruction during the hepatic sur-
gery resection in patients with liver cancer. 
Materials and Methods 
Materials used are the previously published articles which 
report cases of hepatic resection surgery of patients with 
liver tumors in combination with hepatic vein and infe-
rior vena cava reconstruction. The particular searches were 
mostly based on an article published by the National Center 
for Biotechnology Information. The titles used to search in 
various search engines and sites were, “hepatic vein recon-
struction,” “inferior vena cava reconstruction,” “hepatic 
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advances in liver surgery that has enabled live liver donor 
transplantation in some cases. This has increased the sur-
vival rate of most liver cancer patients and has reduced the 
mortality rates during pre- and postoperative care (7). Liver 
resection in a patient with cirrhosis present a higher rate of 
operative mortality as compared to those without liver cir-
rhosis because of inadequate hepatocellular reserves that 
lead to liver failure. Thus, maintaining the active liver mass 
during resection operative procedure in patients with liver 
cirrhosis is very important (8). Tumor cells situated on the 
right lobe of the liver superior segments need resection of 
the hepatic vein by removing the lesser segments that are 
tumor-free. In patients without liver cirrhosis, that is, where 
the hepatic vein functions normally, these inferior segments 
can be included in the resection during right hepatectomy 
to involve the middle hepatic vein where necessary, while in 
patient with cirrhosis, they are preserved if  they are tumor-
free (9). This still needs the reconstruction of the venous out-
flow to hold the required hepatic function. The withdrawal 
of normal liver function as a result of impaired venous out-
flow, especially in the cirrhotic patient, presents a risk during 
a surgical procedure as a result of continuous bleeding from 
the cut wound (10). 
The evaluation of the type and the spread of a tumor into 
the inferior vena cava is very important, and has been made 
better by the availability of the advanced and reliable imaging 
methods, with a multidetector computed tomography report-
ing 78% sensitivity and 96% specificity (3). Malignant tumors 
that invade the inferior vena cava are mostly renal cell can-
cer cells, and hence can be excisional by thrombectomy tech-
niques or removal of tumor affected cells with an artificial 
vessel. Other advanced tumors like the testicular tumors and 
leiomyosarcomas which attacks the walls of the inferior vena 
cava as well as the hepatic vein require total excision of infe-
rior vena cava or hepatic vein during the tumor resection as 
a method of total control (6). In this study, two patients were 
reported to have severe stenosis and developed a deep vein 
thrombosis after radical resection of the inferior vena cava 
resulting in venous complications such as edema of the limbs. 
Therefore, replacement of these inferior vena cava should 
be for the benefit of the patient (8). 
The necessity for the graft material to be used in the recon-
struction of hepatic vein or inferior vena cava should be lim-
ited based on the underlying risk factors and the degree of 
postoperative complications. This involvement of hepatic 
vein and inferior vena cava allows the excellent access of 
reconstruction for implantation, thereby allowing the liver to 
function normally by rotating to the surface of the operative 
field (10, 11). The applications of liver resection techniques 
and reconstructions of both inferior vena cava and hepatic 
vein promote the role of the liver in resection and is bene-
ficial to some particular patients, thus requiring specialized 
centers with specialized medical personnel to administer (2). 
surgery resection,” “liver resection,” or “liver tumor correc-
tion.” Exclusion criteria were applied to the entire articles 
that were not published in English, those with duplicate 
information, and those with surgical therapeutic procedures 
that did not involve hepatic vein/inferior vena cava recon-
struction or liver/hepatic resection. The remaining articles 
were then assessed based on their relevance to the title of the 
discussion. Thus, hepatic vein and inferior vena cave recon-
struction in hepatic surgery resection on patients with hepatic 
tumors were extracted from the final selected articles. The 
indications of hepatic vein and inferior vena cava reconstruc-
tion and the results after restoration were also investigated. 
Results 
In the inclusion criteria after the literature search, only 10 
articles met the required standards to be included in the 
study. These articles have been included as the referencing 
section and a total of 21 cases were involved. The patients 
with liver cancer who underwent hepatic resection were as 
follows: the number of testicular tumor was four, leiomyo-
sarcomas were two, metastatic liver tumor of the colon were 
two, hepatoblastoma were two, cholangiocarcinoma was 
one, and the other 10 had other types of cancer. Eleven of 
the total number presented prevailing conditions of liver cir-
rhosis while the rest were presented without liver cirrhosis 
(1, 3–5). Surgical procedures were examined based on cancer 
grade and liver function in the research studies. The type of 
hepatic resection was based on the hepatic vein and inferior 
vena cava reconstruction, that is, where the small involve-
ment primary repair was considered, and also the effect of 
liver cirrhosis on the hepatic reconstruction. Primary hepatic 
resection involved includes hepatectomy, nephrectomy, ret-
roperitoneal tumor extirpation, lymph node dissection, and 
right trisegmentectomy. Indications of postoperative recon-
structions were also mentioned. Postoperative complications 
were reported and risks of cirrhosis during therapeutic sur-
gical intervention were also reported (6). Causes of opera-
tive mortality were identified with most of them being a liver 
failure, rejection of the grafted organ, bleeding, and multiple 
organ failure were observed. Most of the resected cases had 
longer periods of survival after the hepatic resection. 
Discussion 
Most articles showed that traditionally, resections of liver 
cancers targeting the hepatic veins and inferior vena cava 
were thought to be impossible before the invention of organ 
transplantations (5). In contemporary period, there has been 
a rising application of hepatic vein and inferior vena cava 
reconstruction in hepatic surgical resection for advanced 
liver cancer as a result of the long-term poor prognosis and 
risks involved (4). This has been made possible due to the 
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In conclusion, the availability of innovative surgical tech-
niques that promotes the applications and usability of exten-
sive hepatic vein and inferior vena cava reconstruction in 
liver resection, surgical death, and postoperative complica-
tions remains at significant levels. 
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